'Zero' Demand: Ferrari Is Reportedly Delaying Its Second EV
Electric performance cars have proven to be a hard sell. Even Mate Rimac, who started a company that makes EV hypercars,
thinks so,
and that's proving to be bad news for Ferrari. Reuters, citing anonymous sources,
reports that Ferrari is delaying its second EV from 2026 to 2028,
because right now, there's evidently "zero" demand for such a car.
The Reuters story,
which
The Drive
brought to our attention
, says that Ferrari's first EV will be a low-volume special model, and a "symbolic milestone model that will meet its promise to launch its first EV in 2026." The second electric Ferrari, which was supposed to arrive by the end of next year, will be a higher-volume production car.
Ferrari sells around 5,000 to 6,000 examples of each regular-production model over a five-year run, but one of Reuters' sources said that would be impossible with an EV arriving next year. There's virtually no customer interest, so Ferrari is delaying the model until 2028 at the earliest.
This additional time also has the side benefit of allowing Ferrari to further develop its EV technology. We reported previously
Ferrari has applied for patents on a virtual engine-and-transmission system for electric cars
, not unlike what Hyundai has done successfully with the Ioniq 5 N. Still, one of Reuters' sources said that the main reason for the delay is the demand issue, not anything having to do with the car itself.
Ferrari isn't the only Italian performance-car brand to delay its electric performance car plans. As Reuters notes, Lamborghini
pushed back the launch for its first EV from 2028 to 2029
, and
Maserati outright killed the electric MC20
.
EV demand is slower than many automakers once anticipated, and regulatory pushes to end gas-car production have been either delayed or abandoned entirely. For Ferrari, a wait-and-see approach might not be such a bad thing, rather than committing to something it might not need to build after all. Or, customers might suddenly embrace performance EVs at a greater rate.
More on Ferrari's EV
The Electric Ferrari Isn't Coming This Year
Ferrari's EV Has a Fake Exhaust Noise. Here's What It Sounds Like
Get the best news, reviews, columns, and more delivered straight to your inbox, daily.
back
Sign up
For more information, read our
Privacy Policy
and
Terms of Use
.
Share this Story
Facebook
X
LinkedIn
Flipboard
Reddit
WhatsApp
E-Mail
Got a tip for us? Email:
tips@motor1.com
Join the conversation
(
)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
22 minutes ago
- Bloomberg
Sabadell's Oliu Aims to Keep BBVA at Bay With Surprise TSB Move
Buying TSB Banking Group Plc was arguably Josep Oliu's biggest strategic gamble as chairman of Banco Sabadell SA. Selling it a decade later may yet bring redemption. The announcement Monday that the Spanish lender will consider offers for its UK unit has added a major twist to Oliu's year-long battle to fend off a hostile takeover by BBVA SA under Chairman Carlos Torres. A successful disposal would hand Sabadell proceeds for other strategic options and remove the asset from the reach of the larger rival.
Yahoo
22 minutes ago
- Yahoo
FTSE 100 LIVE: Stocks rise as UK inflation slows ahead of Bank of England decision
The FTSE 100 (^FTSE) and European stocks climbed higher on Wednesday as UK inflation slowed to 3.4% in May amid an easing of transport costs. This was down from 3.5% in April, according to the Office for National Statistics, in line with City economists' forecasts but well above the central bank's 2% target. Transport prices rose by 0.7% in the 12 months to May, down from 3.3% in the year to April, reflecting drops in air fares (which jumped in April) and petrol prices, together with the correction of an error in vehicle excise duty prices. The largest downward contribution came from transport while upward momentum came from food, and furniture and household goods, the ONS said. Core inflation, which excludes food and energy, softened, falling from 3.8% to 3.5% — again matching forecasts. Money Markets still expect the Bank of England to hold interest rates on Thursday, with traders pencilling in a 10% chance of a cut. A reduction in August seems more likely and the City is still expecting two more quarter-point cuts to the base rate by the end of the year, from its current 4.25%. London's benchmark index (^FTSE) was 0.2% higher in early trade Germany's DAX (^GDAXI) rose 0.2% and the CAC (^FCHI) in Paris also headed 0.2% into the green The pan-European STOXX 600 (^STOXX) was treading water after opening Wall Street is set for a positive start as S&P 500 futures (ES=F), Dow futures (YM=F) and Nasdaq futures (NQ=F) were all in the green. The pound was 0.2% higher against the US dollar (GBPUSD=X) at 1.3466 Follow along for live updates throughout the day: Rachel Reeves has said she knows there is 'more to do' as the inflation figure came in well above the Bank of England's 2% target. The chancellor said on Wednesday: Meanwhile, the shadow chancellor Sir Mel Stride, from the opposition Conservative party, said: Transport costs eased last month, pushing overall inflation lower. This was the largest downward contribution partially offsetting upward contributions from food, and furniture and household goods. The average price of petrol dropped by 2.1p between April and May to 132.4p per litre, compared with 148.8p in May 2024. Diesel prices fell 2.6p to 139.1p per litre, down from 156.3p a year earlier. Food and non-alcoholic drink prices picked up. Inflation in this category rose to 4.4% in the 12 months to May, up from 3.4% in April — the highest rate since February 2024, when it stood at 5%. The ONS said that the prices of chocolate, confectionery and ice cream rose between April and May but fell between the same months a year ago. It also said that meat prices rose by more this year than during the same period of 2024. ONS acting chief economist Richard Heys said: UK inflation fell to 3.4% in May, in line with economists' expectations, offering fresh evidence that price pressures may be starting to ease as the Bank of England prepares to announce its latest interest rate decision. The drop comes after inflation hit a 14-month high of 3.5% in April, driven by a wave of household bill increases. However, the Office for National Statistics (ONS) said an error in vehicle tax data meant April's inflation rate should have been 3.4%. Despite the mistake, the ONS has not issued an official revision. Core inflation, which excludes food and energy, also softened, falling from 3.8% to 3.5% — again matching forecasts. The statistics office said transport prices rose by 0.7% in the 12 months to May, down from 3.3% in the 12 months to April, reflecting drops in air fares (which jumped in April) and petrol prices, together with the correction of the error in vehicle excise duty prices. The latter was overstated in April and the series corrected from May. As is standard practice, the April figure has not been revised, the ONS said. Asian equity markets were mixed overnight, with the Hang Seng index (^HSI) leading the losses in the region, declining 1.1%. The Shanghai Composite ( was treading water while the Nikkei (^N225) defied the regional trend, advancing 0.9% to a four-month high, supported by a weaker yen. It came as Japan's exports in May fell 1.7% year-on-year, marking the most significant decline since September 2024, as the nation continues to face trade uncertainties. This drop was less severe than the 3.7% fall anticipated by Bloomberg, but represents a reversal from the 2.0% increase recorded in April. Japan's trade deficit swelled to -637.6bn yen in May, which is smaller than the expected -896.5bn yen, compared to a revised deficit of -115.6bn yen the previous month. Meanwhile the Kospi (^KS11) also made gains, up 0.7% on the day. Across the pond on Wall Street, the US dollar held onto most of its gains against its peers but stocks stayed under pressure. The Dow Jones (^DJI) finished 0.7% lower, at 42,215.80, and the S&P 500 (^GSPC) fell 0.8% to 5,982.72. Apart from energy, all the major sector groups lost ground, including the Magnificent 7 (-1.06%). The tech-heavy Nasdaq (^IXIC) shed 0.9%, closing at 19,521.09. One of the negative drivers on Tuesday was underwhelming US data across the board. Retail sales fell 0.9% in May, compared to the 0.6% fall expected, which was a second consecutive monthly decline. Industrial production also fell 0.2% in May (versus an expected no change). However, some of the core measures fared better, and the retail control group was up 0.4%, compared to the 0.3% expected. In the bond market, the yield on benchmark 10-year US Treasury notes dropped to 4.389% last night, from 4.454% late on Monday. Good morning, and welcome back to our markets live blog. As usual we will be taking a deep dive into what's moving markets and happening across the global economy. For the day ahead, the main highlight will be the Federal Reserve's latest policy decision, along with chair Powell's subsequent press conference. Data releases include US housing starts and building permits for May, the weekly initial jobless claims, and the UK CPI print for May. ECB speakers include Elderson, Escriva, Villeroy, Knot, Panetta, Nagel, Centeno and Lane. Here's a snapshot of what's on the agenda: G-7 leaders meeting day 2 7am: UK inflation data 9.30am: UK house prices and rents 10am: Eurozone inflation (final) for May 12pm: US MBA Mortgage Applications 1.30pm: US Housing starts for May and initial jobless claims 7pm: US Federal Reserve interest rate decision (no change expected)Rachel Reeves has said she knows there is 'more to do' as the inflation figure came in well above the Bank of England's 2% target. The chancellor said on Wednesday: Meanwhile, the shadow chancellor Sir Mel Stride, from the opposition Conservative party, said: Transport costs eased last month, pushing overall inflation lower. This was the largest downward contribution partially offsetting upward contributions from food, and furniture and household goods. The average price of petrol dropped by 2.1p between April and May to 132.4p per litre, compared with 148.8p in May 2024. Diesel prices fell 2.6p to 139.1p per litre, down from 156.3p a year earlier. Food and non-alcoholic drink prices picked up. Inflation in this category rose to 4.4% in the 12 months to May, up from 3.4% in April — the highest rate since February 2024, when it stood at 5%. The ONS said that the prices of chocolate, confectionery and ice cream rose between April and May but fell between the same months a year ago. It also said that meat prices rose by more this year than during the same period of 2024. ONS acting chief economist Richard Heys said: UK inflation fell to 3.4% in May, in line with economists' expectations, offering fresh evidence that price pressures may be starting to ease as the Bank of England prepares to announce its latest interest rate decision. The drop comes after inflation hit a 14-month high of 3.5% in April, driven by a wave of household bill increases. However, the Office for National Statistics (ONS) said an error in vehicle tax data meant April's inflation rate should have been 3.4%. Despite the mistake, the ONS has not issued an official revision. Core inflation, which excludes food and energy, also softened, falling from 3.8% to 3.5% — again matching forecasts. The statistics office said transport prices rose by 0.7% in the 12 months to May, down from 3.3% in the 12 months to April, reflecting drops in air fares (which jumped in April) and petrol prices, together with the correction of the error in vehicle excise duty prices. The latter was overstated in April and the series corrected from May. As is standard practice, the April figure has not been revised, the ONS said. Asian equity markets were mixed overnight, with the Hang Seng index (^HSI) leading the losses in the region, declining 1.1%. The Shanghai Composite ( was treading water while the Nikkei (^N225) defied the regional trend, advancing 0.9% to a four-month high, supported by a weaker yen. It came as Japan's exports in May fell 1.7% year-on-year, marking the most significant decline since September 2024, as the nation continues to face trade uncertainties. This drop was less severe than the 3.7% fall anticipated by Bloomberg, but represents a reversal from the 2.0% increase recorded in April. Japan's trade deficit swelled to -637.6bn yen in May, which is smaller than the expected -896.5bn yen, compared to a revised deficit of -115.6bn yen the previous month. Meanwhile the Kospi (^KS11) also made gains, up 0.7% on the day. Across the pond on Wall Street, the US dollar held onto most of its gains against its peers but stocks stayed under pressure. The Dow Jones (^DJI) finished 0.7% lower, at 42,215.80, and the S&P 500 (^GSPC) fell 0.8% to 5,982.72. Apart from energy, all the major sector groups lost ground, including the Magnificent 7 (-1.06%). The tech-heavy Nasdaq (^IXIC) shed 0.9%, closing at 19,521.09. One of the negative drivers on Tuesday was underwhelming US data across the board. Retail sales fell 0.9% in May, compared to the 0.6% fall expected, which was a second consecutive monthly decline. Industrial production also fell 0.2% in May (versus an expected no change). However, some of the core measures fared better, and the retail control group was up 0.4%, compared to the 0.3% expected. In the bond market, the yield on benchmark 10-year US Treasury notes dropped to 4.389% last night, from 4.454% late on Monday. Good morning, and welcome back to our markets live blog. As usual we will be taking a deep dive into what's moving markets and happening across the global economy. For the day ahead, the main highlight will be the Federal Reserve's latest policy decision, along with chair Powell's subsequent press conference. Data releases include US housing starts and building permits for May, the weekly initial jobless claims, and the UK CPI print for May. ECB speakers include Elderson, Escriva, Villeroy, Knot, Panetta, Nagel, Centeno and Lane. Here's a snapshot of what's on the agenda: G-7 leaders meeting day 2 7am: UK inflation data 9.30am: UK house prices and rents 10am: Eurozone inflation (final) for May 12pm: US MBA Mortgage Applications 1.30pm: US Housing starts for May and initial jobless claims 7pm: US Federal Reserve interest rate decision (no change expected)
Yahoo
23 minutes ago
- Yahoo
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Market View 2025 - Commercial Sponsors Have Led Clinical Trials, with ArmaGen Heading Four Trials
Explore the competitive landscape of Mucopolysaccharidosis I (Hurler syndrome) Therapeutics. In 2024, over 1,740 cases were diagnosed across 16 countries. With one FDA-approved drug, the pipeline holds 16 promising molecules. Key insights into market trends, clinical trials, and player strategies are detailed. Dublin, June 18, 2025 (GLOBE NEWSWIRE) -- The "Mucopolysaccharidosis I (MPS I) (Hurler syndrome): Market View" report has been added to report provides a data-driven overview of the current and future competitive landscape in Mucopolysaccharidosis I (Hurler syndrome) Therapeutics. In 2024, there were over 1,740 diagnosed prevalent cases across 16 countries included in the epidemiology forecast. Currently, only one FDA-approved innovator drug is available for MPS I treatment. The pipeline includes 16 molecules, with one in Phase III development. Over the past decade, commercial sponsors have led clinical trials, with ArmaGen heading four trials. Partnerships have been a significant portion of transactions across North America, Europe, and the Asia-Pacific region during this period. Reasons to Buy Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Develop business strategies by understanding the trends shaping and driving the Mucopolysaccharidosis I (Hurler syndrome) Therapeutics market. Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the global Mucopolysaccharidosis I (Hurler syndrome) Therapeutics market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors. Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. Organize your sales and marketing efforts by identifying the market categories that present the maximum opportunities for consolidations, investments, and strategic partnerships. Key Topics Covered: 1 Preface1.1 Contents1.2 Report Scope1.3 List of Tables and Figures1.4 Abbreviations2 Key Findings3 Disease Landscape3.1 Disease Overview3.2 Epidemiology Overview3.3 Treatment Overview4 Marketed Drugs Assessment4.1 Leading Marketed Drugs4.2 Overview by Mechanism of Action4.3 Overview by Molecule Type4.4 Product Profiles and Sales Forecast5 Pricing and Reimbursement Assessment5.1 Annual Cost of Therapy5.2 Time to Pricing and Reimbursement6 Pipeline Drugs Assessment6.1 Mid-to-late-stage Pipeline Drugs6.2 Overview by Development Stage6.3 Overview by Mechanism of Action6.4 Overview by Molecule Type6.5 Drug Specific Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA)6.6 Therapy Area and Indication-specific PTSR and LoA7 Clinical Trials Assessment7.1 Historical Overview7.2 Overview by Phase7.3 Overview by Status7.4 Overview by Phase for Ongoing and Planned Trials7.5 Trials with Virtual Components7.6 Overview of Trials by Geography7.7 Single-Country and Multinational Trials by Region7.8 Top 20 Sponsors with Breakdown by Phase7.9 Top 20 Sponsors with Breakdown by Status7.10 Overview by Endpoint Status7.11 Overview by Race and Ethnicity7.12 Enrollment Data7.13 Top 20 countries for Trial Sites7.14 Top 20 Sites Globally7.15 Feasibility Analysis - Geographic Overview7.16 Feasibility Analysis - Benchmark Models8 Deals Landscape8.1 Mergers, Acquisitions, and Strategic Alliances by Region8.2 Recent Mergers, Acquisitions, and Strategic Alliances9 Commercial Assessment9.1 Key Market Players10 Future Market Catalysts11 Appendix11.1 Methodology11.2 Methodology - Sales Forecast11.3 Methodology - Pricing and Reimbursement11.4 Methodology - PTSR and LoA AnalysisFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
